Evidence map›Paper›PMID 35083184›Full record

ArticleFrontiers in pediatrics2021

Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!

Pascal André, Léonore Diezi, Kim Dao, Pierre Alex Crisinel, Laura E Rothuizen, Haithem Chtioui, Laurent Arthur Decosterd, Manuel Diezi, Sandra Asner, Thierry Buclin

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06293677 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

Upwards Initial Adjustment of Wide-Spectrum Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Suspected Augmented Renal Clearance: A Randomized Controlled Trial With Therapeutic Drug Monitoring

TypeinterventionalSponsorCentre Hospitalier Universitaire VaudoisRan2024 to 2026Enrolled30ConditionsFebrile NeutropeniaArmsDosage Adjustment Rules for Augmented Renal Clearance (DAR-ARC) for piperacillin-tazobactam and meropenem, Standard dosages of piperacillin-tazobactam or meropenem
NCT07484633 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Protocol of a Randomised, Two-arm Superiority Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients

TypeinterventionalSponsorSemmelweis UniversityRan2026 to 2028Enrolled110ConditionsInfection, Sepsis, NICU, PICUArmsExtended infusion time of the following beta-lactam: meropenem, Short-term infusion time of the following beta-lactam: meropenem, Extended infusion time of the following beta-lactam: piperacillin/tazobactam, Extended infusion time of the following beta-lactam: cefepime, Extended infusion time of the following beta-lactam: ceftriaxone
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Prevalence and Associated Explanatory Factors for Augmented Renal Clearance in Early Sepsis: Single-Center, Retrospective PICU Cohort in China, 2022-2023.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Pascal AndréService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Léonore DieziService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Kim DaoService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Pierre Alex CrisinelPediatric Infectious Diseases and Vaccinology Unit, Service of Pediatrics, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Laura E RothuizenService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Haithem ChtiouiService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Laurent Arthur DecosterdService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Manuel DieziPediatric Hemato-Oncology Unit, Service of Pediatrics, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Sandra AsnerPediatric Infectious Diseases and Vaccinology Unit, Service of Pediatrics, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
Thierry BuclinService of Clinical Pharmacology, University Hospital Center, University of Lausanne, Lausanne, Switzerland.
University of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

augmented renal clearancebeta-lactamscancerchildkidney function testsmeropenemneoplasmspiperacillin

Identifiers

PMID35083184
PMCPMC8785252
OpenAlexW4205592215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.